ICCC Immucell Corp.

$ICCC Nice gain, but expected positive EPS results. Where do you all guess the price may be after whatever re-tain data is released? The chart isn't going to help much as we are getting close to all time forever highs, which appear to be 12.50. Then combine that with next Q I am shooting for 25 after re-tain and after 1st q results. So 4 more months. Hard to say, my guess is they will release some sort of report about re-tain, but the big news will be a partner. I don't think they can sit on the re-tain data waiting for license news. I have low expectations for a buyout. What are your quesses?

$ICCC ImmuCell pre-released Q3 sales after the close Monday: 8.0 million dollars, up 46% YoY. Domestic sales were 6.9 million, up 29.2%, and nine-month sales are 25.6 million, up 27.8%. Growth was broad across the portfolio. Tri-Shield grew 51%, Dual-Force 36%, and the recently launched functional feed line 37%. Management flagged the comp itself though. Q3 last year was depressed because distributors had pulled purchases forward into Q2 2025, so part of that 46% is a soft base. This is also the last early sales release. ImmuCell is dropping preliminary reporting, so the full print on Nov. 13 is the next read.